Inventor · disambiguated record
Yingzi Xu
Also filed as: XU YINGZI
7 granted patents·7 pending applications·22 citations·filing 2019–2025
79Inventor score
Top patents by PatentIndex Score
14 records- 0192US12240835B2Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activityTERNS PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·1 cites·4 claims
- 0291US11203587B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Dec 21, 2021·6 cites·21 claims
- 0391US10800767B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Oct 13, 2020·11 cites·21 claims
- 0490US10889571B2Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemiasTERNS INC·Filed 2019·Granted Jan 12, 2021·4 cites·34 claims
- 0578US12454524B2(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemiasTERNS PHARMACEUTICALS INC·Filed 2025·Granted Oct 28, 2025·0 cites·30 claims
- 0674US2025276961A1Compounds for treating certain leukemiasTERNS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0772US2025236615A1Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2024·Application pending·0 cites
- 0867US2022348561A1Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0963US2023322744A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1056US2024116912A1Compounds and methods for modulating fxrTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1156US2024059682A1Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1251US12398127B2Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2020·Granted Aug 26, 2025·0 cites·19 claims
- 1350US2022362245A1Compounds for inhibiting fgfr4TERNS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1446US10919911B2Tricyclic ASK1 inhibitorsTERNS INC·Filed 2019·Granted Feb 16, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Yingzi Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →